Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro

Surgical Neurology

Volumn 65, Issue 5, 2006, Pages 478-484

  Altinoz, Meric A ^a,b   Bilir, Ayhan ^c   Del Maestro, Rolando F ^d   Tuna, Sevilcan ^c   Ozcan, Emin ^e   Gedikoglu, Gunduz ^a,b  

^a HALIC UNIVERSITY   (Turkey)

^b Our Children Leukemia Foundation   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d MCGILL UNIVERSITY   (Canada)

^e Bakirkoy State Hospital   (Turkey)

Author keywords

Brain tumor; C6 glioma; Diltiazem; Glia; Noscapine; Radiation; Taxol

Indexed keywords

DILTIAZEM; NOSCAPINE; PACLITAXEL;

ARTICLE; AUTOPHAGY; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE S PHASE; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; STRUCTURE ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; DILTIAZEM; DRUG SYNERGISM; GLIOMA; HUMANS; MICROSCOPY, ELECTRON; MITOCHONDRIA; NOSCAPINE; P-GLYCOPROTEIN; PACLITAXEL; S PHASE; TUMOR STEM CELL ASSAY;

EID: 33646039750     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2005.06.024     Document Type: Article

References (36)

1. Asai A., Miyagi Y., Sugiyama A., Gamanuma M., Hong S.H., Takamoto S., Nomura K., Matsutani M., Takakura K., and Kuchino Y. Negative effects of wild-type p53 and s-myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol 19 (1984) 259-268
2. Camilleri-Broet S., Vanderwerff H., Caldwell E., and Hockenbery D. Distinct alterations in mitochondrial mass and function characterize different models of apoptosis. Exp Cell Res 239 (1998) 277-292
3. Cornwell M.M., Pastan I., and Gottesman M.M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262 (1987) 2166-2170
4. Fellner S., Bauer B., Miller D.S., Schaffrik M., Fankhanel M., Spruss T., Bernhardt G., Graeff C., Farber L., Gschaidmeier H., Buschauer A., and Fricker G. Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest 110 (2002) 1309-1318
5. Gong Y., Wang Y., Chen F., Han J., Miao J., Shao N., Fang Z., and Ou Yang R. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. Leuk Res 24 (2000) 769-774
6. Gupta N., Hu L.J., and Deen D.F. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys 37 (1997) 885-895
7. Hong F.D., Chen J., Donovan S., Schneider N., and Nisen P.D. Taxol, vincristine or nocodazole induces lethality in G1-checkpoint-defective human astrocytoma U373MG cells by triggering hyperploid progression. Carcinogenesis 20 (1999) 1161-1168
8. Huet S., Chapey C., and Robert J. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells. Eur J Cancer 29A (1993) 1377-1383
9. Jensen R.L., Origitano T.C., Lee Y.S., Weber M., and Wurster R.D. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36 (1995) 365-373
10. Jensen R.L., and Wurster R.D. Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. Surg Neurol 55 (2001) 275-283
11. Karbowski M., Spodnik J.H., Teranishi M., Wozniak M., Nishizawa Y., Usukura J., and Wakabayashi T. Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells. J Cell Sci 114 (2001) 281-291
12. Ke Y., Ye K., Grossniklaus H.E., Archer D.R., Joshi H.C., and Kapp J.A. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother 49 (2000) 217-225
13. Kondo T., Habara Y., Kanno T., and Kano E. Thermosensitization and modification of cytosolic calcium concentration by verapamil and diltiazem in mouse mammary carcinoma cells. Int J Radiat Oncol Biol Phys 29 (1994) 511-517
14. Landen J.W., Lang R., McMahon S.J., Rusan N.M., Yvon A.M., Adams A.W., Sorcinelli M.D., Campbell R., Bonaccorsi P., Ansel J.C., Archer D.R., Wadsworth P., Armstrong C.A., and Joshi H.C. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. Cancer Res 62 (2002) 4109-4114
15. Lazo J.S., Schisselbauer J.C., Herring G.M., and Kennedy K.A. Involvement of the cellular vacuolar system with the cytotoxicity of bleomycin-like agents. Cancer Commun 2 (1990) 81-86
16. Lederman G., Arbit E., Odaimi M., Wertheim S., and Lombardi E. Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol. Stereotact Funct Neurosurg 69 (1997) 162-174
17. Lee H.C., Yin P.H., Lu C.Y., Chi C.W., and Wei Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 348 (2000) 425-432
18. 2+ channel antagonists. Mol Chem Neuropathol 22 (1994) 81-95
19. Lum B.L., Gosland M.P., Kaubisch S., and Sikic B.I. Molecular targets in oncology: implications of the multidrug resistance gene. Pharmacotherapy 13 (1993) 88-109
20. Mancini M., Anderson B.O., Caldwell E., Sedghinasab M., Paty P.B., and Hockenbery D.M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 138 (1997) 449-469
21. Muruganandham M., Kasiviswanathan A., Jagannathan N.R., Raghunathan P., Jain P.C., and Jain V. Diltiazem enhances tumor blood flow: MRI study in a murine tumor. Int J Radiat Oncol Biol Phys 43 (1999) 413-421
22. Porter L.A., and Lee J.M. Alpha-, beta-, and gamma-tubulin polymerization in response to DNA damage. Exp Cell Res 270 (2001) 151-158
23. Saito Y., Mitsuhashi N., Sakurai H., Ishikawa H., Hasegawa M., Akimoto T., Hayakawa K., and Niibe H. Apoptosis and appearance of Trp53-positive micronuclei in murine tumors with different radioresponses in vivo. Radiat Res 152 (1999) 462-467
24. Sawada T., Kato Y., Sakayori N., Takekawa Y., and Kobayashi M. Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors. Brain Tumor Pathol 16 (1999) 23-27
25. Taylor J.M., and Simpson R.U. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res 52 (1992) 2413-2418
26. Toth K., Vaughan M.M., Peress N.S., Slocum H.K., and Rustum Y.M. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol 149 (1996) 853-858
27. Tsuiki H., Nitta M., Tada M., Inagaki M., Ushio Y., and Saya H. Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. Oncogene 20 (2001) 420-429
28. Wehbe T., Glantz M., Choy H., Glantz L., Cortez S., Akerley III W., Mills P., and Cole B. Histologic evidence of a radiosensitizing effect of Taxol in patients with astrocytomas. J Neurooncol 39 (1998) 245-251
29. Woloschak G.E., Shearin-Jones P., and Chang-Liu C.M. Effects of ionizing radiation on expression of genes encoding cytoskeletal elements: kinetics and dose effects. Mol Carcinog 3 (1990) 374-378
30. Yao S.L., Akhtar A.J., McKenna K.A., Bedi G.C., Sidransky D., Mabry M., Ravi R., Collector M.I., Jones R.J., Sharkis S.J., Fuchs E.J., and Bedi A. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med 2 (1996) 1140-1143
31. Ye K., Ke Y., Keshava N., Shanks J., Kapp J.A., Tekmal R.R., Petros J., and Joshi H.C. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci U S A 95 (1998) 1601-1606
32. Ye K., Zhou J., Landen J.W., Bradbury E.M., and Joshi H.C. Sustained activation of p34(cdc2) is required for noscapine-induced apoptosis. J Biol Chem 276 (2001) 46697-46700
33. Zacharski L.R., Moritz T.E., Haakenson C.M., O'Donnell J.F., Ballard H.S., Johnson G.J., Ringenberg Q.S., Schilsky R.L., Spaulding M.B., and Tornyos K. Chronic calcium antagonist use in carcinoma of the lung and colon: a retrospective cohort observational study. Cancer Invest 8 (1990) 451-458
34. Zeitler H., Ko Y., Glodny B., Totzke G., Appenheimer M., Sachinidis A., and Vetter H. Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers. Cancer Detect Prev 21 (1997) 332-339
35. Zenke K., Nakagawa K., Kumon Y., Ohta S., Hatakeyama T., and Sakaki S. A strategy for selective anti-cancer drug concentration increase in rat glioma tissue with Ca(2+)-channel blocker co-administration: calcium kinetics in intra-glioma arteriolar smooth muscle cells. J Neurooncol 30 (1996) 25-36
36. Zhou J., Gupta K., Yao J., Ye K., Panda D., Giannakakou P., and Joshi H.C. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine. J Biol Chem 277 (2002) 39777-39785